8:00 AM ET
8-K
Leadership Change
Harmony Biosciences Holdings Leadership Change
Harmony Biosciences announced that Jeffrey M. Dayno, M.D., will retire as President, CEO, and Director effective December 31, 2026. Peter Anastasiou, the company's current Chief Operating Officer and former board member, has been appointed to succeed him as President, CEO, and Director effective January 1, 2027. Dr. Dayno will remain with the company as a non-executive advisor through 2027 to support the transition.